June 01, 2010
ASKLEP Establishes Representative Office in Shanghai, China
ASKLEP Inc., a CRO with headquarters in Tokyo, is pleased to announce the opening of their first overseas office located in Shanghai, China.
While clinical research development is growing at lightening speed in the Asia region, ASKLEP is on the ground in this vital market, to provide clients with in-depth consulting services for market and drug information in the clinical development arena. ASKLEP has already executed strategic partnership agreements with a Taiwan CRO, Qualitix Clinical Research and with a Korean CRO, DreamCIS Inc. Through these alliances, ASKLEP has established a structure where they can conduct and manage trials in East Asia among these three countries. By adding Shanghai Representative Office in China, ASKLEP has accelerated and expanded beyond these territories by moving into mainland China. This reinforces ASKLEP's commitment to providing clients with a full spectrum of services and greater geographic coverage.
Corporate Profile
Company Name: ASKLEP Inc. Shanghai Representative Office
Address: The Exchange-SOHO16F No.1486, Nanjing Road West, Jing'an District, Shanghai, China
Establishment: June 2, 2010
About Asklep
Asklep, Inc., (www.asklep.co.jp) founded in 1992, in Tokyo, Japan, provides clinical research services in monitoring, data management, biostatistics, regulatory & consulting, CRA training, etc. ASKLEP is an INTAGE Group Company. INTAGE, INC., (www.intage.co.jp) is the largest marketing research company in Japan and the eleventh largest globally. It has one of the most comprehensive healthcare solution services in the industry.
For further information please contact
ASKLEP Inc. Corporate Planning and Development
INTAGE Akihabara Bldg., 3 Kanda Neribei-cho Chiyoda-ku, Tokyo 101-8202 Japan
Phone: +81-3-5294-5222
Inquires by mail：http://www.asklep.co.jp/english/contact/
